Celgene Corporation Privacy and Data Protection Policy
Celgene Corporation recognizes the importance of protecting the privacy of information we collect from visitors to our websites. To this end, we are committed to using our best efforts to respect our visitors’ privacy. While the security of information in transit over the Internet cannot be assured, our privacy practices are designed to give customers choices and control over personally identifiable information and to ensure that we use information we receive in ways compatible with the purposes for which it has been collected by the individual. We have established this privacy policy for the Celgene Corporation global network of websites and are posting it here so that you can understand the care with which we intend to treat your information.
What information do we collect and how do we use it?
Some of the information we keep on our Web server is information that site visitors volunteer to provide through forms and some is collected automatically. We only collect personally identifiable data, such as your name or e-mail address or geographic location, when it is voluntarily submitted to us.
Our server automatically collects information in aggregate form to track the total number of visitors to our site, the number of visitors to each page of our site, and the domain names of our visitors' Internet service providers. No personally identifiable information is collected automatically. We use this aggregate information to help us better understand site visitors’ needs and to improve our products and services.
In some places on our site, Celgene uses a technology called cookies. A cookie is a token that a server gives to your browser when you access a Web page. Cookies help provide additional functionality, making a visit to our websites more efficient for the visitor. The use of cookies allows us to collect more accurate information regarding aggregate use of our websites. In order to provide the highest possible level of customer service, cookies allow us to track paths through the site to identify users’ unmet information needs. We do not collect personally identifiable data through cookies.
Celgene offers site visitors the option of submitting a resume for employment consideration. Resumes submitted through our website are shared only internally or with vendors Celgene has engaged to assist us with our Human Resource processes. Any vendors or service organizations Celgene engages to assist us are also required to follow this Privacy Policy.
Visitors to our website may e-mail us from time to time with requests for information. The information provided in these e-mail messages is used to respond to your request.
Celgene websites are not intended or designed for children under the age of 13. We do not collect personally identifiable data from any person we know to be under the age of 13.
With whom do we share the information we collect?
We do not share information we collect from our websites with other organizations except for members of the Celgene group of companies in the United States, the European Union, and elsewhere, vendors or service organizations we have engaged to assist us with completing a service (a CME organization to award continuing medical education credits for example), or unless required by law (reporting safety information to regulatory authorities for example). Any vendor or service organization to which we provide such information is also required to follow this Privacy Policy. We do not sell or rent personal information to other organizations for their commercial use. We do not partner with or have special relationships with any ad server companies.
Some users of our websites are invited to participate in nonpublic, secure (password-protected) sites. Members who choose to participate in these sites also have access to their own and other members’ profile information, including personal contact information.
How can site visitors view, change, or delete their information?
You may have access to your personal information at any time to revise, correct, or delete it by contacting us. For previous submissions related to Medical Services please contact Medinfo@celgene.com. For previous submissions related to Career and Employment please contact Careersnj@celgene.com. For previous submissions related to Investor Relations requests please contact IR@celgene.com. For previous submissions related to Patient Support contact Patientsupport@celgene.com. For all other inquiries please e-mail us at Privacy@celgene.com.
How is personal information secured and protected?
Personally identifiable data are stored in secure databases relevant for the purposes for which it was collected that are accessible only to authorized Celgene employees and contracted vendors.
What is the policy related to third-party sites?
Celgene provides links to third-party sites as a convenience to our site visitors. Links to third-party sites do not constitute an endorsement or a warranty of any kind. Celgene is not responsible for the privacy practices or the content of such websites. We suggest contacting these sites directly for information on their data collection and distribution policies.
What if this Privacy Policy changes?
From time to time, we may use website visitor information for new, unanticipated uses not previously disclosed in our Privacy Policy. Any changes to our Privacy Policy will be promptly communicated on this page. We will also send visitors for whom we have a valid e-mail address a notice through e-mail with a link to this page and provide an option to opt out of new uses.
How can I contact you to get more information?
If you have questions about this Privacy Policy, the practices of this site, or your dealings with this website, please contact us. We will address any issue to the best of our ability. You can contact us via e-mail at Privacy@celgene.com or by phone at +1-908-673-9000, or by postal mail at:
Celgene Corporate Headquarters
Attn: Privacy Matters
86 Morris Avenue
Summit, NJ 07901
Last Updated December 14, 2009
ABRAXANE is a prescription medicine for breast cancer that has spread to other parts of the body. ABRAXANE is used after treatment with combination chemotherapy has stopped working, including anthracyclines, if appropriate, or when the cancer has come back within 6 months of treatment after surgery.
Important Safety Information About ABRAXANE®
WARNING: ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) should be given only by a doctor who is experienced in giving chemotherapy. That way, if any problems come up during treatment, your doctor will be able to manage them.
If you have a low white blood cell count (neutropenia), you should not take ABRAXANE, since you may be more likely to get a serious infection. While taking ABRAXANE, you must get regular blood tests to check for any problems that could develop.
ABRAXANE contains albumin, a substance found in human blood. Albumin can affect the way other drugs work.
- ABRAXANE has not been studied in people with kidney problems
- If you are pregnant, or become pregnant, ABRAXANE can cause harm to your unborn baby. You should avoid becoming pregnant while taking ABRAXANE
- Men should not father a child while being treated with ABRAXANE
- If you have a very low white blood cell count, you should not take ABRAXANE. If your white blood cell count goes down while taking ABRAXANE, you should stop taking it until your white blood cell count returns to normal. If your white blood cell count drops very low, your doctor will lower your dose of ABRAXANE
- It is not known whether ABRAXANE interacts with other drugs, so be sure to tell your doctor about any medicines you are taking
- People treated with ABRAXANE often have a side effect called sensory neuropathy, a numbness, tingling, or burning in the hands, feet, and ankles. If you get mild sensory neuropathy, you will probably not have to lower your dose of ABRAXANE. If sensory neuropathy becomes severe, you may have to stop taking ABRAXANE until it improves, and then continue treatment at a lower dose
- Treatment with ABRAXANE can make liver problems worse. If you have liver problems, your starting dose of ABRAXANE should be lowered
- Treatment with ABRAXANE can cause irritation where the medicine is injected (injection site reactions). When taking ABRAXANE, you should be monitored by your doctor or nurse to make sure no problems occur at the injection site
- Since it is not known if ABRAXANE passes into human milk, you should stop nursing if you are taking ABRAXANE
- You should not drive a car when you are being treated with ABRAXANE. Side effects such as feeling very tired (fatigue), having no energy (lethargy), or feeling sick (malaise) can affect your ability to drive or use machinery
- In a clinical trial, severe heart and blood vessel side effects occurred in approximately 3% of women taking ABRAXANE. Side effects included chest pain, heart attack, fluid under the skin, blood clots in the veins or lungs, and high blood pressure. Stroke and heart failure were rare
- The most important side effects during treatment with ABRAXANE included hair loss, low white blood cell count, sensory neuropathy, weakness, muscle or joint pain, low red blood cell count (anemia), nausea, diarrhea, infection, vomiting, and sores in the mouth or on the lips (mucositis)
- Other side effects included vision problems, kidney problems, fluid retention, liver problems, and allergic reactions, and a decrease in blood clotting cells (platelets). Dehydration and fever were common
Please see full Prescribing Information, including Boxed WARNINGS, CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS, and ADVERSE REACTIONS.